Videos While Biogen rides a big-cap rollercoaster, a few small players are creating better trading opps. Articles You May Like This 38-year-old is financially independent with passive income. Here’s how he built a 7-figure real estate portfolio Nine killed and thousands injured as Hizbollah pagers explode in Lebanon Top Wall Street analysts pick these dividend stocks for attractive returns FINRA fines BNY Pershing $42,000 Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors